These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2482105)

  • 61. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
    Kask A; Harro J
    Neuropharmacology; 2000 Apr; 39(7):1292-302. PubMed ID: 10760371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of dihydropyridine drugs on reversal by imipramine of helpless behavior in rats.
    Martin P; Laurent S; Massol J; Childs M; Puech AJ
    Eur J Pharmacol; 1989 Mar; 162(1):185-8. PubMed ID: 2470601
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies on interactions between conditioned and unconditioned behavioural responses to apomorphine in rats.
    Möller HG; Nowak K; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):673-9. PubMed ID: 3627283
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat.
    Bourson A; Moser PC; Gower AJ; Mir AK
    Eur J Pharmacol; 1989 Feb; 160(3):339-47. PubMed ID: 2469593
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Central control of the baroreflex response to phenylephrine by dihydropyridines in the anesthetized rat].
    Lacolley P; Laurent S; Tsoucaris-Kupfer D; Legrand M; Brisac AM; Schmitt H
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():119-23. PubMed ID: 2461181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enantiomer selectivity and the development of tolerance to the behavioral effects of the calcium channel activator BAY K 8644.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1988 Dec; 21(6):865-72. PubMed ID: 2465070
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
    Meier K; Knepel W; Schöfl C
    Endocrinology; 1988 Jun; 122(6):2764-70. PubMed ID: 2453348
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1987; 93(3):336-42. PubMed ID: 3124163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Some central pharmacological effects of the calcium channel antagonist flunarizine.
    Czyrak A; Mogilnicka E; Maj J
    J Neural Transm Gen Sect; 1991; 83(3):179-88. PubMed ID: 2031709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A; Leino T; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sexual behavior in male rats after radiofrequency or dopamine-depleting lesions in nucleus accumbens.
    Liu YC; Sachs BD; Salamone JD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):585-92. PubMed ID: 9632244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys.
    Rosenzweig-Lipson S; Barrett JE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):842-51. PubMed ID: 7543574
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of behavioral effects of cathinone, amphetamine and apomorphine.
    Schechter MD; Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1984 Feb; 20(2):181-4. PubMed ID: 6718445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atypical neuroleptic-like behavioral effects of neurotensin.
    Jolicoeur FB; Gagné MA; Rivest R; Drumheller A; St-Pierre S
    Brain Res Bull; 1993; 32(5):487-91. PubMed ID: 8106129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine.
    Fink JS; Smith GP
    Brain Res; 1980 Nov; 201(1):107-27. PubMed ID: 7191345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.